{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:49:30Z","timestamp":1772837370658,"version":"3.50.1"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01 HL021796"],"award-info":[{"award-number":["5R01 HL021796"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01 HL086741"],"award-info":[{"award-number":["5R01 HL086741"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 EB024308"],"award-info":[{"award-number":["R21 EB024308"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009429","name":"Israel National Road Safety Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R21 EB024308"],"award-info":[{"award-number":["R21 EB024308"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["5T32 HL007734"],"award-info":[{"award-number":["5T32 HL007734"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.avsg.2024.01.031","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T16:26:07Z","timestamp":1712247967000},"page":"229-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Advancements in Omics and Breakthrough Gene Therapies: A Glimpse into the Future of Peripheral Artery Disease"],"prefix":"10.1016","volume":"107","author":[{"given":"Phillip G.","family":"Brennan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Aridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyah","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patric","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3379-7998","authenticated-orcid":false,"given":"Christiane","family":"Ferran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2024.01.031_bib1","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2024.01.031_bib3","first-page":"932","article-title":"Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule","volume":"56","author":"Bendermacher","year":"2006","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.avsg.2024.01.031_bib4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0002-9149(00)00694-9","article-title":"Patterns of atherosclerosis: effect of risk factors on recurrence and survival-analysis of 11,890 cases with more than 25-year follow-up","volume":"85","author":"DeBakey","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.avsg.2024.01.031_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Ankle Brachial Index","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.avsg.2024.01.031_bib7","doi-asserted-by":"crossref","first-page":"786.e1","DOI":"10.1016\/j.ahj.2005.11.004","article-title":"The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design","volume":"151","author":"Ohman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.avsg.2024.01.031_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yasu.2023.04.009","article-title":"Current management of intermittent claudication","volume":"57","author":"Stonko","year":"2023","journal-title":"Adv Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib9","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.ejvs.2019.04.009","article-title":"Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization","volume":"58","author":"Simons","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib10","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jvs.2023.01.200","article-title":"Updated estimates for the burden of chronic limb-threatening ischemia in the Medicare population","volume":"77","author":"Kwong","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jvs.2017.06.102","article-title":"Estimated annual health care expenditures in individuals with peripheral arterial disease","volume":"67","author":"Scully","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease\u00a0(TASC II)","volume":"33 Suppl 1","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jvs.2023.05.040","article-title":"Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI trial","volume":"78","author":"Siracuse","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib14","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jvs.2020.03.029","article-title":"Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia","volume":"72","author":"Perlander","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.avsg.2021.07.050","article-title":"Reinterventions in patients with claudication and chronic limb threatening ischemia","volume":"79","author":"Mohamedali","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib16","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1038\/s41467-020-19505-2","article-title":"The once and future gene therapy","volume":"11","author":"Bulaklak","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.avsg.2024.01.031_bib17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib18","article-title":"Gene therapy for peripheral arterial disease","volume":"10","author":"Forster","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.avsg.2024.01.031_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: a brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib20","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/CIRCULATIONAHA.120.048378","article-title":"Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human","volume":"142","author":"Pan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1251141","article-title":"Single-cell RNA sequencing investigation of female-male differences under PAD conditions","volume":"10","author":"Sanchez Marrero","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCRESAHA.123.323161","article-title":"Single-nuclei RNA-sequencing of the gastrocnemius muscle in peripheral artery disease","volume":"133","author":"Pass","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/bjs.1800810904","article-title":"Pathobiology of intimal hyperplasia","volume":"81","author":"Davies","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: a revolutionary tool for transcriptomics","volume":"10","author":"Wang","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.avsg.2024.01.031_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3892\/mmr.2022.12855","article-title":"Comparison of single-nucleus and single-cell transcriptomes in hepatocellular carcinoma tissue","volume":"26","author":"Wen","year":"2022","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.avsg.2024.01.031_bib26","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1007\/s00018-021-03916-5","article-title":"Quality control in scRNA-Seq can discriminate pacemaker cells: the mtRNA bias","volume":"78","author":"Galow","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.avsg.2024.01.031_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.avsg.2024.01.031_bib28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","article-title":"Multiplex digital spatial profiling of proteins and RNA in fixed tissue","volume":"38","author":"Merritt","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.avsg.2024.01.031_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41592-019-0691-5","article-title":"Single-cell multimodal omics: the power of many","volume":"17","author":"Zhu","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.avsg.2024.01.031_bib30","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/TP.0000000000004466","article-title":"The utility of spatial transcriptomics for solid organ transplantation","volume":"107","author":"Li","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.avsg.2024.01.031_bib31","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2147\/JIR.S405903","article-title":"The technical feasibility of digital spatial profiling in immune\/inflammation study of thrombosis","volume":"16","author":"Jiang","year":"2023","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","article-title":"Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics","volume":"22","author":"Longo","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.avsg.2024.01.031_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrg.2015.16","article-title":"Single-cell genome sequencing: current state of the science","volume":"17","author":"Gawad","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.avsg.2024.01.031_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40119-023-00303-y","article-title":"Application of single-cell genomics in cardiovascular research","volume":"12","author":"Yu","year":"2023","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002862","article-title":"Genome-wide association study of peripheral artery disease","volume":"14","author":"van Zuydam","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001393","article-title":"Comparative analysis of proteome and transcriptome variation in mouse","volume":"7","author":"Ghazalpour","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.avsg.2024.01.031_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1074\/mcp.M200008-MCP200","article-title":"Discordant protein and mRNA expression in lung adenocarcinomas","volume":"1","author":"Chen","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.avsg.2024.01.031_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.avsg.2024.01.031_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-62703-392-3_16","article-title":"Proteomic strategies to characterize signaling pathways","volume":"1007","author":"Harsha","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026945","article-title":"NLRP3 inflammasome activation in peripheral arterial disease","volume":"12","author":"Bartoli-Leonard","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2024.01.031_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2022.102693","article-title":"Single-cell metabolomics: where are we and where are we going?","volume":"75","author":"Lanekoff","year":"2022","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.avsg.2024.01.031_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11306-022-01934-3","article-title":"Single cell metabolism: current and future trends","volume":"18","author":"Ali","year":"2022","journal-title":"Metabolomics"},{"key":"10.1016\/j.avsg.2024.01.031_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021995","article-title":"Metabolic biomarker discovery for risk of peripheral artery disease compared with coronary artery disease: lipoprotein and metabolite profiling of 31 657 individuals from 5 prospective cohorts","volume":"10","author":"Tikkanen","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2024.01.031_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.talanta.2015.10.070","article-title":"Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: a pilot study","volume":"148","author":"Garcia-Fontana","year":"2016","journal-title":"Talanta"},{"key":"10.1016\/j.avsg.2024.01.031_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.758085","article-title":"Exercise-induced plasma metabolomic profiles in patients with\u00a0peripheral arterial disease","volume":"12","author":"Sempore","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.avsg.2024.01.031_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.766739","article-title":"Impacts of cigarette smoking status on metabolomic and gut microbiota profile in male patients with coronary artery disease: a multi-omics study","volume":"8","author":"Hu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40168-020-00821-0","article-title":"Gut microbiota and cardiovascular disease: opportunities and challenges","volume":"8","author":"Kazemian","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.avsg.2024.01.031_bib49","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/microorganisms10102065","article-title":"Plasma gut microbe-derived metabolites associated with peripheral artery disease and major adverse cardiac events","volume":"10","author":"Ho","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.avsg.2024.01.031_bib50","doi-asserted-by":"crossref","first-page":"796","DOI":"10.5551\/jat.3285","article-title":"Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet","volume":"17","author":"Stepankova","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.avsg.2024.01.031_bib51","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.gpb.2023.01.002","article-title":"Artificial intelligence in omics","volume":"20","author":"Gao","year":"2022","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.avsg.2024.01.031_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1199087","article-title":"A review of multi-omics data integration through deep learning approaches for disease diagnosis, prognosis, and treatment","volume":"14","author":"Wekesa","year":"2023","journal-title":"Front Genet"},{"issue":"Suppl 6","key":"10.1016\/j.avsg.2024.01.031_bib54","article-title":"Role of lipoprotein (a) in peripheral arterial disease","volume":"7","author":"Kosmas","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10408363.2017.1415866","article-title":"Lipoprotein(a) in clinical practice: new perspectives from basic and translational science","volume":"55","author":"Scipione","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.avsg.2024.01.031_bib56","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41591-019-0492-5","article-title":"Genome-wide association study of peripheral artery disease in the Million Veteran program","volume":"25","author":"Klarin","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib57","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.avsg.2024.01.031_bib58","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1194\/jlr.M036343","article-title":"MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma","volume":"54","author":"Wiesner","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/923289","article-title":"Lipoprotein(a): cellular effects and molecular mechanisms","volume":"2012","author":"Riches","year":"2012","journal-title":"Cholesterol"},{"key":"10.1016\/j.avsg.2024.01.031_bib60","doi-asserted-by":"crossref","first-page":"55187","DOI":"10.1074\/jbc.M409860200","article-title":"Stimulation of\u00a0vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-\u03b2 activation and on the presence of Kringle IV type 9","volume":"279","author":"O'Neil","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.avsg.2024.01.031_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10557-016-6648-3","article-title":"Human genetics and the causal role of lipoprotein(a) for various diseases","volume":"30","author":"Kronenberg","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib62","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCRESAHA.121.318327","article-title":"Genetic determinants of peripheral artery disease","volume":"128","author":"Klarin","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCGENETICS.110.958371","article-title":"Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the heart protection study","volume":"4","author":"Hopewell","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.avsg.2024.01.031_bib64","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib65","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib66","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib67","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib68","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib69","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8129513","article-title":"Advantages and disadvantages of inclisiran: a small interfering ribonucleic acid molecule targeting PCSK9\u2014a narrative review","volume":"2022","author":"Mer\u0107ep","year":"2022","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.122.062132","article-title":"Efficacy and safety of an investigational single-course CRISPR base-editing therapy targeting PCSK9 in nonhuman primate and mouse models","volume":"147","author":"Lee","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/diseases6030063","article-title":"Inclisiran: a new promising agent in the management of hypercholesterolemia","volume":"6","author":"Kosmas","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.avsg.2024.01.031_bib73","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.3390\/jcm11164872","article-title":"Role of lipid-lowering therapy in peripheral artery disease","volume":"11","author":"Belur","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib74","unstructured":"Oxford Uo. HPS-4\/TIMI 65\/ORION-4: a double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease [clinical trial registration]. clinicaltrials.gov. Available at: https:\/\/clinicaltrials.gov\/study\/NCT03705234. Accessed November 31, 2023."},{"key":"10.1016\/j.avsg.2024.01.031_bib75","first-page":"e282","article-title":"Safety and pharmacodynamic effects of VERVE-101, an investigational DNA base editing medicine designed to durably inactivate the PCSK9 gene and lower LDL cholesterol - interim results of the phase 1b heart-1 trial","volume":"148","author":"Vafai","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib76","doi-asserted-by":"crossref","first-page":"18068","DOI":"10.1074\/jbc.271.30.18068","article-title":"A20 blocks endothelial cell activation through a NF-\u03baB-dependent mechanism","volume":"271","author":"Cooper","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.avsg.2024.01.031_bib77","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1182\/blood.V91.7.2249","article-title":"A20 inhibits NF-\u03baB activation in endothelial cells without sensitizing to tumor necrosis factor\u2013mediated apoptosis","volume":"91","author":"Ferran","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.avsg.2024.01.031_bib78","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","article-title":"Failure to regulate TNF-induced NF-kB and cell death responses in A20-deficient mice","volume":"289","author":"Lee","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.avsg.2024.01.031_bib79","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1096\/fj.05-4981com","article-title":"A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia","volume":"20","author":"Patel","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.avsg.2024.01.031_bib80","doi-asserted-by":"crossref","first-page":"30912","DOI":"10.1074\/jbc.M114.591966","article-title":"A20 regulates atherogenic interferon (IFN)-\u03b3 signaling in vascular cells by modulating basal IFN\u03b2 levels","volume":"289","author":"Moll","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.avsg.2024.01.031_bib81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/TP.0b013e3182419829","article-title":"A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis","volume":"93","author":"Siracuse","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.avsg.2024.01.031_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.651230","article-title":"A20\/TNFAIP3 increases ENOS expression in an ERK5\/KLF2-dependent manner to support endothelial cell health in the face of inflammation","volume":"8","author":"Angolano","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib83","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1182\/blood-2003-02-0635","article-title":"A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by\u00a0inhibiting caspase 8 activation","volume":"104","author":"Daniel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.avsg.2024.01.031_bib84","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.transproceed.2006.10.167","article-title":"The universal NF-kappaB inhibitor A20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells","volume":"38","author":"Daniel","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.avsg.2024.01.031_bib85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11373-007-9150-x","article-title":"A20 attenuates vascular smooth muscle cell proliferation and migration through blocking PI3k\/Akt singling in\u00a0vitro and in\u00a0vivo","volume":"14","author":"Wang","year":"2007","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.avsg.2024.01.031_bib86","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.bbamcr.2008.01.029","article-title":"Localization of A20 to a lysosome-associated compartment and its role in NF\u03baB signaling","volume":"1783","author":"Li","year":"2008","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib87","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2010.03.029","article-title":"A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization","volume":"211","author":"Damrauer","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.avsg.2024.01.031_bib88","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1097\/TP.0000000000001407","article-title":"A20 haploinsufficiency aggravates transplant arteriosclerosis in mouse vascular allografts: implications for clinical transplantation","volume":"100","author":"Moll","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.avsg.2024.01.031_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014240","article-title":"O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice","volume":"5","author":"Shrikhande","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2024.01.031_bib90","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jamcollsurg.2011.07.006","article-title":"Thrombospondin-2 gene silencing in human aortic smooth muscle cells improves cell attachment","volume":"213","author":"Yoshida","year":"2011","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib91","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.biocel.2004.01.012","article-title":"The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury","volume":"36","author":"Bornstein","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib92","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jss.2003.12.014","article-title":"Temporal gene expression following prosthetic arterial grafting","volume":"120","author":"Willis","year":"2004","journal-title":"J Surg Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039123","article-title":"Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury","volume":"7","author":"Bhasin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2024.01.031_bib94","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1096\/fj.201600501r","article-title":"Intraluminal delivery of thrombospondin-2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model","volume":"31","author":"Bodewes","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.avsg.2024.01.031_bib95","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301359R","article-title":"Perivascular CLICK-gelatin delivery of thrombospondin-2 small interfering RNA decreases development of intimal hyperplasia after arterial injury","volume":"38","author":"Mota","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.avsg.2024.01.031_bib96","article-title":"Deficiency of thrombospondin-2 alleviates intimal hyperplasia in mice by modulating vascular smooth muscle cell proliferation and migration","volume":"37","author":"Li","year":"2023","journal-title":"FASEB J"},{"issue":"Pt 19","key":"10.1016\/j.avsg.2024.01.031_bib97","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1242\/jcs.01309","article-title":"The bi-directional translocation of MARCKS between membrane and cytosol regulates integrin-mediated muscle cell spreading","volume":"117","author":"Disatnik","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.avsg.2024.01.031_bib98","doi-asserted-by":"crossref","first-page":"C1611","DOI":"10.1152\/ajpcell.2000.279.5.C1611","article-title":"Role of MARCKS in regulating endothelial cell proliferation","volume":"279","author":"Zhao","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.avsg.2024.01.031_bib99","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.biolcel.2003.09.005","article-title":"Myoblast migration is prevented by a calpain-dependent accumulation of MARCKS","volume":"95","author":"Dedieu","year":"2003","journal-title":"Biol Cell"},{"issue":"Pt 3","key":"10.1016\/j.avsg.2024.01.031_bib100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1042\/BJ20040347","article-title":"Myristoylated alanine-rich C kinase substrate (MARCKS) is involved in myoblast fusion through its regulation by protein kinase Calpha and calpain proteolytic cleavage","volume":"382","author":"Dulong","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.avsg.2024.01.031_bib101","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jvs.2018.12.022","article-title":"The myristoylated alanine-rich C kinase substrate differentially regulates kinase interacting with stathmin in vascular smooth muscle and endothelial cells and potentiates intimal hyperplasia formation","volume":"70","author":"Yu","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141397","article-title":"MARCKS signaling differentially regulates vascular smooth muscle and endothelial cell proliferation through a KIS-, p27kip1- dependent mechanism","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2024.01.031_bib103","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002255","article-title":"Myristoylated alanine-rich protein kinase substrate (MARCKS) regulates\u00a0small GTPase Rac1 and Cdc42 activity and is a critical mediator of vascular smooth muscle cell migration in intimal hyperplasia formation","volume":"4","author":"Yu","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2024.01.031_bib104","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1096\/fj.08-114173","article-title":"MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein","volume":"23","author":"Monahan","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.avsg.2024.01.031_bib105","first-page":"153","article-title":"Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states","volume":"15","author":"Tran","year":"2022","journal-title":"Am J Biomed Sci Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib106","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib107","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2741\/3828","article-title":"Nitric oxide signalling in the regulation of cardiovascular and platelet function","volume":"16","author":"Gkaliagkousi","year":"2011","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.avsg.2024.01.031_bib108","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/01.CIR.98.12.1212","article-title":"Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells","volume":"98","author":"Iwashina","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib109","doi-asserted-by":"crossref","first-page":"L452","DOI":"10.1152\/ajplung.00378.2002","article-title":"TNF-\u03b1 induces a decrease in eNOS promoter activity","volume":"286","author":"Neumann","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.avsg.2024.01.031_bib110","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.4049\/jimmunol.166.6.3873","article-title":"Biphasic regulation of NF-\u03baB activity underlies the pro- and anti-inflammatory actions of nitric oxide","volume":"166","author":"Connelly","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.avsg.2024.01.031_bib111","doi-asserted-by":"crossref","first-page":"A64","DOI":"10.1016\/j.jvs.2007.02.027","article-title":"The role of nitric oxide in the pathophysiology of intimal hyperplasia","volume":"45","author":"Ahanchi","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib112","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1111\/bph.13815","article-title":"Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system","volume":"174","author":"Cirino","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.avsg.2024.01.031_bib113","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0741-5214(98)70300-3","article-title":"Hemagglutinating virus of Japan-liposome\u2013mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff","volume":"27","author":"Matsumoto","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib114","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1067\/msy.2002.124878","article-title":"Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: a limited biological effect as a result of the loss of medial smooth muscle cells","volume":"131","author":"Ohta","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.avsg.2024.01.031_bib115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trsl.2012.12.003","article-title":"Gene therapy for the prevention of vein graft disease","volume":"161","author":"Southerland","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib116","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(10)61996-4","article-title":"Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies","volume":"377","author":"Reilly","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2024.01.031_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22174","article-title":"Genetic variants rs1994016 and rs3825807 in ADAMTS7 affect its mRNA expression in atherosclerotic occlusive peripheral arterial disease","volume":"32","author":"Bayoglu","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.avsg.2024.01.031_bib118","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.atherosclerosis.2013.02.039","article-title":"Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction","volume":"228","author":"Setten","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.avsg.2024.01.031_bib119","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCRESAHA.108.188425","article-title":"ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries","volume":"104","author":"Wang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11427-015-4843-2","article-title":"ADAMTS-7 promotes vascular smooth muscle cells proliferation in\u00a0vitro and in\u00a0vivo","volume":"58","author":"Zhang","year":"2015","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.avsg.2024.01.031_bib121","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/CIRCULATIONAHA.114.012669","article-title":"Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice","volume":"131","author":"Bauer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib122","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.122.061516","article-title":"Peptide vaccine against ADAMTS-7 ameliorates atherosclerosis and postinjury neointima hyperplasia","volume":"147","author":"Ma","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8770","article-title":"PDGFR\u03b2 signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis","volume":"6","author":"He","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.avsg.2024.01.031_bib124","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cytogfr.2004.03.004","article-title":"PDGF and cardiovascular disease","volume":"15","author":"Raines","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.avsg.2024.01.031_bib125","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.ATV.15.4.522","article-title":"Effects of platelet-derived growth factor on the synthesis of lipoprotein lipase in human monocyte\u2013derived macrophages","volume":"15","author":"Inaba","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib126","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3892\/etm.2015.2275","article-title":"Expression of platelet-derived growth factor in the vascular walls of patients with lower extremity arterial occlusive disease","volume":"9","author":"Zhang","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib127","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.avsg.2024.01.031_bib128","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.RES.81.3.320","article-title":"Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo","volume":"81","author":"Mondy","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib129","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1073\/pnas.71.4.1207","article-title":"A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro","volume":"71","author":"Ross","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.avsg.2024.01.031_bib130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejmhg.2017.03.004","article-title":"Association assessment of platelet derived growth factor B gene polymorphism and its expression status with susceptibility to coronary artery disease","volume":"18","author":"Rezayani","year":"2017","journal-title":"Egypt J Med Hum Genet"},{"key":"10.1016\/j.avsg.2024.01.031_bib131","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41591-022-01891-3","article-title":"Large-scale genome-wide association study of coronary artery disease in genetically diverse populations","volume":"28","author":"Tcheandjieu","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib132","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/ATVBAHA.121.317007","article-title":"Twenty-five novel loci for carotid intima-media thickness: a genome-wide association study in >45 000 individuals and meta-analysis of >100 000 individuals","volume":"42","author":"Yeung","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib133","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/ATVBAHA.115.305513","article-title":"Systems genetics analysis\u00a0of genome-wide association study reveals novel associations between key biological processes and coronary artery disease","volume":"35","author":"Ghosh","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib134","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1653454","article-title":"Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF","volume":"253","author":"Ferns","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.avsg.2024.01.031_bib135","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.CIR.95.3.669","article-title":"Antisense oligonucleotide inhibition of PDGFR-\u03b2 receptor subunit expression directs suppression of intimal thickening","volume":"95","author":"Sirois","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib136","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3892\/mmr.2016.5986","article-title":"A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model","volume":"15","author":"Huang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.avsg.2024.01.031_bib137","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1158\/0008-5472.CAN-09-3722","article-title":"Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma","volume":"70","author":"Huang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib138","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/ph3030572","article-title":"Platelet-derived growth factor (PDGF)\/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy","volume":"3","author":"Raica","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.avsg.2024.01.031_bib139","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.avsg.2024.01.031_bib140","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/ATVBAHA.122.318902","article-title":"Gene therapeutic strategies for peripheral artery disease and new opportunities provided by adeno-associated virus vectors","volume":"43","author":"Khachigian","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib142","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.avsg.2024.01.031_bib143","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant adeno-associated virus gene therapy in light of Luxturna (and Zolgensma and Glybera): where are we, and how did we get here?","volume":"6","author":"Keeler","year":"2019","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.avsg.2024.01.031_bib144","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","article-title":"The clinical landscape for AAV gene therapies","volume":"20","author":"Kuzmin","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.avsg.2024.01.031_bib145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.avsg.2024.01.031_bib146","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.99.2.201","article-title":"Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors","volume":"99","author":"Svensson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib147","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.avsg.2024.01.031_bib148","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/gt.2013.13","article-title":"Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy","volume":"20","author":"Lompr\u00e9","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib149","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jgm.1133","article-title":"Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5","volume":"10","author":"Sen","year":"2008","journal-title":"J Gene Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymthe.2003.11.006","article-title":"Development of efficient viral vectors selective for vascular smooth muscle cells","volume":"9","author":"Work","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib151","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/mt.2011.237","article-title":"Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector","volume":"20","author":"Bowles","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib152","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ymthe.2005.11.013","article-title":"Vascular bed-targeted in\u00a0vivo gene delivery using tropism-modified adeno-associated viruses","volume":"13","author":"Work","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib153","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gt.2011.143","article-title":"Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors","volume":"19","author":"Varadi","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib154","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jss.2011.02.032","article-title":"Successful transfection of genes using AAV-2\/9 vector in swine coronary and peripheral arteries","volume":"175","author":"Pankajakshan","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib155","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.1996.157","article-title":"Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells","volume":"49","author":"van Det","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.avsg.2024.01.031_bib156","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cm.20430","article-title":"High glucose-mediated loss of cell surface heparan sulfate proteoglycan impairs the endothelial shear stress response","volume":"67","author":"Brower","year":"2010","journal-title":"Cytoskeleton"},{"key":"10.1016\/j.avsg.2024.01.031_bib157","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.avsg.2024.01.031_bib158","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1093\/nar\/gkq206","article-title":"The siRNA sequence and guide strand overhangs are determinants of in\u00a0vivo duration of silencing","volume":"38","author":"Strapps","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib159","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","article-title":"Therapeutic siRNA: state-of-the-art and future perspectives","volume":"36","author":"Friedrich","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.avsg.2024.01.031_bib160","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jvs.2006.04.044","article-title":"Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts","volume":"44","author":"Banno","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib161","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.jss.2011.03.060","article-title":"Small interfering RNA to c-myc inhibits vein graft restenosis in a rat vein graft model","volume":"169","author":"Wang","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib162","first-page":"233","article-title":"Current siRNA targets in atherosclerosis and aortic aneurysm","volume":"17","author":"Pradhan-Nabzdyk","year":"2014","journal-title":"Discov Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib163","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.M012872","article-title":"siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids","volume":"52","author":"Tadin-Strapps","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib164","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/ph13100294","article-title":"Overcoming barriers for siRNA therapeutics: from bench to bedside","volume":"13","author":"Sajid","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.avsg.2024.01.031_bib165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ajps.2018.12.005","article-title":"Design, mechanism, delivery and therapeutics of canonical and dicer-substrate siRNA","volume":"14","author":"Raja","year":"2019","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.avsg.2024.01.031_bib166","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm1191","article-title":"Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7","volume":"11","author":"Hornung","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib167","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2007.06.177","article-title":"Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs","volume":"361","author":"Sioud","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.avsg.2024.01.031_bib168","first-page":"189","article-title":"The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence","volume":"487","author":"Fluiter","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib169","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1093\/nar\/gkq341","article-title":"A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects","volume":"38","author":"Bramsen","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib170","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41467-018-02989-4","article-title":"Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity","volume":"9","author":"Janas","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.avsg.2024.01.031_bib171","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jamcollsurg.2006.12.029","article-title":"Comparison of gene silencing in human vascular cells using small interfering RNAs","volume":"204","author":"Andersen","year":"2007","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib172","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib173","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2017.12.001","article-title":"Quantitative contributions of processes by which polyanion drugs reduce intracellular bioavailability and transfection efficiency of cationic siRNA lipoplex","volume":"270","author":"Jaiprasart","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.avsg.2024.01.031_bib174","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2020.07.022","article-title":"Recent advances in siRNA delivery mediated by lipid-based nanoparticles","volume":"154-155","author":"Yonezawa","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.avsg.2024.01.031_bib175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molcel.2019.02.015","article-title":"RNA circularization diminishes immunogenicity and can extend translation duration in\u00a0vivo","volume":"74","author":"Wesselhoeft","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.avsg.2024.01.031_bib176","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41392-021-00569-5","article-title":"Targeting circular RNAs as a therapeutic approach: current strategies and challenges","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib177","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.avsg.2024.01.031_bib178","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3389\/fphys.2018.01262","article-title":"Circular RNAs as therapeutic agents and targets","volume":"9","author":"Holdt","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.avsg.2024.01.031_bib179","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","article-title":"Engineering circular RNA for potent and stable translation in eukaryotic cells","volume":"9","author":"Wesselhoeft","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.avsg.2024.01.031_bib180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.avsg.2024.01.031_bib181","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molcel.2019.02.015","article-title":"RNA circularization diminishes immunogenicity and can extend translation duration in\u00a0vivo","volume":"74","author":"Wesselhoeft","year":"2019","journal-title":"Mol cell"},{"key":"10.1016\/j.avsg.2024.01.031_bib182","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.avsg.2024.01.031_bib183","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1261\/rna.079507.122","article-title":"Endosomal escape of RNA therapeutics: how do we solve this rate-limiting problem?","volume":"29","author":"Dowdy","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.avsg.2024.01.031_bib184","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","article-title":"Circular RNA vaccine in disease prevention and treatment","volume":"8","author":"Niu","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001426","article-title":"Readily available tissue-engineered vascular grafts","volume":"3","author":"Dahl","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib186","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cvr\/cvr197","article-title":"Plasmid-mediated gene therapy for cardiovascular disease","volume":"91","author":"Williams","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib187","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.gt.3302534","article-title":"Nuclear entry of nonviral vectors","volume":"12","author":"Dean","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib188","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1016248701505","article-title":"The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake","volume":"12","author":"Kawabata","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib189","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/gt.2011.18","article-title":"Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure","volume":"18","author":"Sundararaman","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1753944718786926","article-title":"Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication","volume":"12","author":"Deev","year":"2018","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.avsg.2024.01.031_bib191","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/gt.2010.51","article-title":"Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia","volume":"17","author":"Shigematsu","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib192","article-title":"Gene therapy for peripheral arterial disease","volume":"10","author":"Forstera","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.avsg.2024.01.031_bib193","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.avsg.2024.01.031_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.avsg.2024.01.031_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106480","article-title":"CRISPR\/CAS9: a promising approach for the research and treatment of cardiovascular diseases","volume":"185","author":"Dong","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib196","first-page":"191","article-title":"The big bang of genome editing technology: development and application of the CRISPR\/Cas9 system in disease animal models","volume":"37","author":"Shao","year":"2016","journal-title":"Dongwuxue Yanjiu"},{"key":"10.1016\/j.avsg.2024.01.031_bib197","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/BTT.S326422","article-title":"Mechanism and applications of CRISPR\/Cas-9-mediated genome editing","volume":"15","author":"Asmamaw","year":"2021","journal-title":"Biol Targets Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib198","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.042476","article-title":"In\u00a0vivo AAV-CRISPR\/Cas9\u2013mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia","volume":"141","author":"Zhao","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib199","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/nar\/gkaa1251","article-title":"Dynamics and competition of CRISPR\u2013Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing","volume":"49","author":"Fu","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.avsg.2024.01.031_bib200","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.avsg.2024.01.031_bib201","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.omtm.2022.10.009","article-title":"LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: a proof-of-concept study","volume":"27","author":"Doerfler","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.avsg.2024.01.031_bib202","first-page":"109","article-title":"Endovascular gene delivery from a stent platform: gene- eluting stents","volume":"1","author":"Fishbein","year":"2013","journal-title":"Angiology: open access"},{"key":"10.1016\/j.avsg.2024.01.031_bib203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7150\/thno.7210","article-title":"Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis","volume":"4","author":"Yin","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.avsg.2024.01.031_bib204","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4068\/cmj.2017.53.1.14","article-title":"Drug- and gene-eluting stents for preventing coronary restenosis","volume":"53","author":"Lekshmi","year":"2017","journal-title":"Chonnam Med J"},{"key":"10.1016\/j.avsg.2024.01.031_bib205","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib206","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.0000133324.38115.0A","article-title":"Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis","volume":"110","author":"Walter","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.01.031_bib207","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1161\/ATVBAHA.107.154609","article-title":"Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys","volume":"27","author":"Egashira","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.01.031_bib208","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/mt.2008.165","article-title":"Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis","volume":"16","author":"Sharif","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib209","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/gt.2011.92","article-title":"Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in\u00a0vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model","volume":"19","author":"Sharif","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.avsg.2024.01.031_bib210","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcin.2019.10.060","article-title":"Pathology and multimodality imaging of acute and chronic femoral stenting in humans","volume":"13","author":"Kuntz","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.01.031_bib211","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/polym12112702","article-title":"Fundamental concepts of hydrogels: synthesis, properties, and their applications","volume":"12","author":"Bashir","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.avsg.2024.01.031_bib212","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.avsg.2024.01.031_bib213","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201902232","article-title":"Local immunomodulation using an adhesive hydrogel loaded with miRNA-laden nanoparticles promotes wound healing","volume":"15","author":"Saleh","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.avsg.2024.01.031_bib214","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2011.01.028","article-title":"Hyaluronic acid and fibrin hydrogels with concentrated DNA\/PEI polyplexes for local gene delivery","volume":"153","author":"Lei","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.avsg.2024.01.031_bib215","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/adhm.201400783","article-title":"Porous hyaluronic acid hydrogels for localized nonviral DNA delivery in a diabetic wound healing model","volume":"4","author":"Tokatlian","year":"2015","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.avsg.2024.01.031_bib216","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.1016\/j.biomaterials.2012.06.096","article-title":"The attenuation of restenosis following arterial gene transfer using carbon nanotube coated stent incorporating TAT\/DNA(Ang1+Vegf) nanoparticles","volume":"33","author":"Paul","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.avsg.2024.01.031_bib217","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0002-9610(87)90803-8","article-title":"Autogenous reversed vein bypass for lower extremity ischemia in patients with absent or inadequate greater saphenous vein","volume":"153","author":"Taylor","year":"1987","journal-title":"Am J Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib218","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1067\/mva.2001.113578","article-title":"Heparin-bonded dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial","volume":"33","author":"Devine","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib219","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0741-5214(86)90073-X","article-title":"Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions","volume":"3","author":"Veith","year":"1986","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib220","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw8682","article-title":"Bioengineered human blood vessels","volume":"370","author":"Niklason","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.avsg.2024.01.031_bib221","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jvs.2008.08.101","article-title":"Long-term experience in autologous in\u00a0vitro endothelialization of infrainguinal ePTFE grafts","volume":"49","author":"Deutsch","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib222","first-page":"47","article-title":"A completely biological tissue-engineered human blood vessel","volume":"12","author":"L'Heureux","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.avsg.2024.01.031_bib223","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.284.5413.489","article-title":"Functional arteries grown in\u00a0vitro","volume":"284","author":"Niklason","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.avsg.2024.01.031_bib224","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(16)00557-2","article-title":"Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials","volume":"387","author":"Lawson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2024.01.031_bib225","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jvs.2019.11.056","article-title":"Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease","volume":"72","author":"Gutowski","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.01.031_bib226","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6934","article-title":"Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation","volume":"11","author":"Kirkton","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.avsg.2024.01.031_bib227","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40759-017-0028-y","article-title":"Experimental and computational studies of poly-l-lactic acid for cardiovascular applications: recent progress","volume":"3","author":"Naseem","year":"2017","journal-title":"Mech Adv Mater Modern Process"},{"key":"10.1016\/j.avsg.2024.01.031_bib228","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002107","article-title":"Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials","volume":"9","author":"Jackson-Smith","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.avsg.2024.01.031_bib229","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ccd.29327","article-title":"Long-term results of a prospective, single-arm evaluation of everolimus-eluting bioresorbable vascular scaffolds in infrapopliteal arteries","volume":"97","author":"Varcoe","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.01.031_bib230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2305637","article-title":"Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease","volume":"390","author":"Varcoe","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:18:26Z","timestamp":1724797106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509624001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":229,"alternative-id":["S0890509624001560"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2024.01.031","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in Omics and Breakthrough Gene Therapies: A Glimpse into the Future of Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2024.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}